Cardinal Health, Inc. (CAH)Â
Largest Insider Buys in Sector
CAH Stock Price History Chart
CAH Stock Performance
About Cardinal Health, Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Insider Activity of Cardinal Health, Inc.
Over the last 12 months, insiders at Cardinal Health, Inc. have bought $0 and sold $22.08M worth of Cardinal Health, Inc. stock.
On average, over the past 5 years, insiders at Cardinal Health, Inc. have bought $29,239 and sold $11.28M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 200 shares for transaction amount of $14,944 was made by Brennan Michelle (director) on 2022‑11‑15.
List of Insider Buy and Sell Transactions, Cardinal Health, Inc.
| 2024-11-14 | Sale | Chief Accounting Officer | 3,504 0.0015% | $123.55 | $432,919 | -0.88% | ||
| 2024-08-21 | Sale | Chief Legal/Compliance Officer | 16,573 0.0068% | $109.39 | $1.81M | +4.99% | ||
| 2024-08-19 | Sale | Chief Executive Officer | 46,455 0.0189% | $109.02 | $5.06M | +4.38% | ||
| 2024-08-19 | Sale | CEO, GMPD Segment | 46,998 0.0192% | $109.21 | $5.13M | +4.38% | ||
| 2024-08-19 | Sale | Chief Financial Officer | 2,323 0.0009% | $108.91 | $252,998 | +4.38% | ||
| 2024-08-19 | Sale | Chief Human Resources Officer | 34,647 0.0141% | $109.00 | $3.78M | +4.38% | ||
| 2024-08-19 | Sale | Chief Information Officer | 4,000 0.0016% | $108.85 | $435,400 | +4.38% | ||
| 2024-08-16 | Sale | Chief Executive Officer | 26,716 0.0119% | $108.87 | $2.91M | 0.00% | ||
| 2024-08-16 | Sale | Chief Human Resources Officer | 3,294 0.0015% | $108.00 | $355,752 | 0.00% | ||
| 2024-08-15 | Sale | Chief Legal/Compliance Officer | 17,896 0.0078% | $106.48 | $1.91M | 0.00% | ||
| 2023-11-27 | Sale | CEO, Pharmaceutical Segment | 36,642 0.0148% | $106.31 | $3.9M | -0.43% | ||
| 2023-08-28 | Sale | CEO, Pharmaceutical Segment | 6,712 0.0027% | $89.81 | $602,805 | +14.72% | ||
| 2023-08-18 | Sale | Chief Accounting Officer | 20,695 0.0082% | $86.27 | $1.79M | +19.33% | ||
| 2023-08-17 | Sale | Chief Legal/Compliance Officer | 10,668 0.0043% | $87.68 | $935,370 | +18.49% | ||
| 2023-08-17 | Sale | CEO, Medical Segment | 37,500 0.0149% | $87.32 | $3.27M | +18.49% | ||
| 2023-08-17 | Sale | Chief Human Resources Officer | 26,324 0.0105% | $87.41 | $2.3M | +18.49% | ||
| 2023-08-17 | Sale | Chief Information Officer | 2,000 0.0008% | $86.79 | $173,580 | +18.49% | ||
| 2023-08-16 | Sale | Chief Legal/Compliance Officer | 30,145 0.0119% | $90.84 | $2.74M | +13.13% | ||
| 2022-11-15 | director | 200 <0.0001% | $74.72 | $14,944 | +15.15% | |||
| 2022-11-14 | director | 200 <0.0001% | $76.30 | $15,260 | +13.61% |
Insider Historical Profitability
| Hollar Jason M. | Chief Executive Officer | 197636 0.0817% | $126.27 | 0 | 2 | |
| Mayer Jessica L | Chief Legal/Compliance Officer | 75971 0.0314% | $126.27 | 0 | 5 | |
| Mason Stephen M | CEO, GMPD Segment | 40671 0.0168% | $126.27 | 0 | 3 | |
| Alt Aaron E | Chief Financial Officer | 36867 0.0152% | $126.27 | 0 | 1 | |
| Snow Ola M | Chief Human Resources Officer | 27516 0.0114% | $126.27 | 2 | 5 | |
| Greene Michelle D. | Chief Information Officer | 19242 0.008% | $126.27 | 0 | 2 | |
| Scherer Mary C. | Chief Accounting Officer | 8752 0.0036% | $126.27 | 0 | 2 | |
| WALTER ROBERT D | director | 937754 0.3875% | $126.27 | 1 | 12 | +9.1% |
| WALTER MATTHEW D | director | 907663 0.3751% | $126.27 | 0 | 7 | |
| Barrett George S | Chairman and CEO | 464231 0.1918% | $126.27 | 0 | 13 | |
| Kaufmann Michael C | Chief Executive Officer | 211849 0.0875% | $126.27 | 0 | 16 | |
| CLARK R KERRY | Former Chairman and CEO | 172680 0.0714% | $126.27 | 1 | 0 | <0.0001% |
| Casey Donald M Jr. | CEO, Medical Segment | 138319 0.0572% | $126.27 | 0 | 2 | |
| Morford Craig S | Chief Legal/Compliance Officer | 90811 0.0375% | $126.27 | 0 | 8 | |
| Lynch Michael A | CEO, Medical Segment | 89204 0.0369% | $126.27 | 0 | 2 | |
| FORD BRENDAN A | EVP-Corporate Development | 87052 0.036% | $126.27 | 1 | 4 | +25.18% |
| FOTIADES GEORGE L | President & COO | 80400 0.0332% | $126.27 | 6 | 2 | <0.0001% |
| Giacomin Jon L | CEO, Medical Segment | 72652 0.03% | $126.27 | 0 | 4 | |
| Henderson Jeffrey William | Chief Financial Officer | 67190 0.0278% | $126.27 | 0 | 17 | |
| GERBIG ROBERT L | director | 66218 0.0274% | $126.27 | 0 | 1 | |
| MORRISON PATRICIA | Chief Information Officer | 36157 0.0149% | $126.27 | 0 | 3 | |
| LABRUM RONALD K | CEO-Supply Chain Svcs. | 36082 0.0149% | $126.27 | 0 | 6 | |
| NOTEBAERT RICHARD C | director | 35778 0.0148% | $126.27 | 0 | 5 | |
| WEITZMAN DEBORAH | CEO, Pharmaceutical Segment | 35202 0.0145% | $126.27 | 0 | 2 | |
| Stephen Falk T | EVP, Gen. Counsel & Corp. Sec. | 33633 0.0139% | $126.27 | 0 | 10 | |
| WATKINS CAROLE S | Chief HR Officer | 31585 0.0131% | $126.27 | 0 | 12 | |
| THOMAS STEPHEN S | EVP-Group Pres.-AIS | 31039 0.0128% | $126.27 | 0 | 1 | |
| HAVENS JOHN F | director | 26034 0.0108% | $126.27 | 0 | 1 | |
| PARRISH MARK W | CEO - HSCS | 25016 0.0103% | $126.27 | 0 | 11 | |
| FINN JOHN F | director | 22957 0.0095% | $126.27 | 0 | 4 | |
| DARDEN CALVIN | director | 22771 0.0094% | $126.27 | 0 | 3 | |
| Arnold Colleen F. | director | 21597 0.0089% | $126.27 | 0 | 2 | |
| Blake Mark R | EVP - Strategy & Corp. Dev. | 20409 0.0084% | $126.27 | 0 | 12 | |
| KENNY GREGORY B | director | 19584 0.0081% | $126.27 | 0 | 1 | |
| SPAULDING JEAN G | director | 17182 0.0071% | $126.27 | 1 | 6 | <0.0001% |
| COX CARRIE SMITH | director | 14129 0.0058% | $126.27 | 1 | 0 | +37.73% |
| SLUSSER ERIC | EVP, CAO & Controller | 8573 0.0035% | $126.27 | 0 | 1 | |
| LAWS STUART G | SVP & Chief Accounting Officer | 6296 0.0026% | $126.27 | 0 | 12 | |
| English Patricia M | Chief Accounting Officer | 6085 0.0025% | $126.27 | 0 | 1 | |
| Brennan Michelle | director | 3324 0.0014% | $126.27 | 3 | 0 | +12.56% |
| ANDERSON DAVID J | director | 3028 0.0013% | $126.27 | 1 | 0 | <0.0001% |
| RAISBECK DAVID W | director | 3000 0.0012% | $126.27 | 1 | 0 | +9.1% |
| MCCOY JOHN B | director | 958 0.0004% | $126.27 | 0 | 2 | |
| DAVIDS JODY R | EVP & CIO | 1000 0.0004% | $126.27 | 0 | 2 | |
| SCHLOTTERBECK DAVID L | Former Vice Chair & CEO CTS | 375 0.0002% | $126.27 | 0 | 3 | |
| JENSEN GARY S | SVP - Corporate Controller | 462 0.0002% | $126.27 | 0 | 2 | |
| JONES CLAYTON M | director | 0 0% | $126.27 | 0 | 1 | |
| KING DAVID P | director | 0 0% | $126.27 | 0 | 1 |
Institutional Investor Ownership
| The Vanguard Group | $3.43B | 12.57 | 30.62M | -2.06% | -$72.26M | 0.06 | |
| BlackRock | $3.06B | 11.22 | 27.34M | +4.76% | +$139.05M | 0.07 | |
| State Street | $1.59B | 5.79 | 14.11M | -2.75% | -$44.84M | 0.07 | |
| Fidelity Investments | $648.59M | 2.38 | 5.8M | +7.13% | +$43.15M | 0.04 | |
| Geode Capital Management | $622.18M | 2.29 | 5.57M | +2.37% | +$14.43M | 0.05 | |
| Morgan Stanley | $488.56M | 1.79 | 4.37M | -2.84% | -$14.3M | 0.04 | |
| Arrowstreet Capital, Limited Partnership | $463.27M | 1.7 | 4.14M | -11.92% | -$62.7M | 0.43 | |
| Pacer Advisors Inc | $417.26M | 1.53 | 3.73M | +42.35% | +$124.14M | 1.06 | |
| Acadian Asset Management | $416.58M | 1.53 | 3.72M | +19.14% | +$66.91M | 1.46 | |
| Ameriprise Financial | $405.53M | 1.49 | 3.62M | -2.83% | -$11.81M | 0.11 | |
| AQR Capital | $401.34M | 1.47 | 3.59M | +25.1% | +$80.53M | 0.63 | |
| Invesco | $364.52M | 1.34 | 3.26M | -14.76% | -$63.13M | 0.08 | |
| Northern Trust | $334.89M | 1.23 | 2.99M | -3.67% | -$12.77M | 0.06 | |
| T. Rowe Price | $305.58M | 1.12 | 2.73M | +0.52% | +$1.57M | 0.04 | |
| Legal & General | $285.71M | 1.05 | 2.55M | +2.09% | +$5.84M | 0.07 | |
| LSV Asset Management | $269.82M | 0.99 | 2.41M | -3.09% | -$8.62M | 0.56 | |
| JPMorgan Chase | $261.95M | 0.96 | 2.34M | +94.02% | +$126.94M | 0.02 | |
| Nuveen | $258.94M | 0.95 | 2.31M | +13.06% | +$29.91M | 0.07 | |
| Bank of America | $235.97M | 0.87 | 2.11M | +11.16% | +$23.7M | 0.02 | |
| Ubs Asset Management Americas Inc | $232.57M | 0.85 | 2.08M | +11.47% | +$23.93M | 0.08 | |
| Elliott Investment Management L P | $223.8M | 0.82 | 2M | 0% | +$0 | 2.35 | |
| Amundi | $211.62M | 0.82 | 2M | -11.02% | -$26.21M | 0.09 | |
| BNY Mellon | $199.43M | 0.73 | 1.78M | -5.56% | -$11.74M | 0.04 | |
| ProShares | $187.33M | 0.69 | 1.67M | -3.28% | -$6.35M | 0.49 | |
| Renaissance Technologies | $175.94M | 0.65 | 1.57M | -14.05% | -$28.76M | 0.28 | |
| CalPERS | $167.13M | 0.61 | 1.49M | -1.49% | -$2.52M | 0.12 | |
| Allianz Asset Management Gmbh | $166.07M | 0.61 | 1.48M | -15.37% | -$30.16M | 0.28 | |
| Charles Schwab | $161.53M | 0.59 | 1.44M | -0.64% | -$1.05M | 0.04 | |
| Man Group Plc | $155.36M | 0.57 | 1.39M | +10.58% | +$14.86M | 0.38 | |
| American Century Investments | $153.12M | 0.56 | 1.37M | -0.74% | -$1.14M | 0.09 | |
| Qube Research & Technologies | $141.72M | 0.52 | 1.27M | -4.95% | -$7.38M | 0.17 | |
| Brandes Investment Partners | $133.63M | 0.49 | 1.19M | -2.21% | -$3.02M | 1.72 | |
| Dimensional Fund Advisors | $130.63M | 0.48 | 1.17M | -18.08% | -$28.83M | 0.03 | |
| Royal Bank of Canada | $127.2M | 0.47 | 1.14M | -19.9% | -$31.59M | 0.03 | |
| Robeco Institutional Asset Management B.V. | $122.95M | 0.45 | 1.1M | +2.13% | +$2.57M | 0.27 | |
| Prudential Financial | $120.58M | 0.44 | 1.08M | -13.99% | -$19.62M | 0.17 | |
| Voloridge Investment Management, LLC | $116.31M | 0.43 | 1.04M | +11.01% | +$11.54M | 0.43 | |
| Holocene Advisors, LP | $112.28M | 0.41 | 1M | +275.58% | +$82.39M | 0.42 | |
| SEB | $111.66M | 0.41 | 997,887 | +58.92% | +$41.4M | 0.51 | |
| Goldman Sachs | $99.18M | 0.36 | 886,285 | -30.59% | -$43.7M | 0.02 | |
| De Depot Et Placement Du Quebec Caisse | $97.38M | 0.36 | 870,230 | +46.23% | +$30.79M | 0.23 | |
| Russell Investments Group Ltd | $91.35M | 0.34 | 814,894 | +25.18% | +$18.37M | 0.13 | |
| UBS | $90.07M | 0.33 | 804,953 | +84.75% | +$41.32M | 0.03 | |
| Deutsche Bank | $89.21M | 0.33 | 797,241 | +13.82% | +$10.83M | 0.04 | |
| Swiss National Bank | $82.6M | 0.3 | 738,200 | -4.17% | -$3.59M | 0.05 | |
| Zurich Insurance Group Ltd Fi | $78.18M | 0.29 | 698,636 | +153.88% | +$47.38M | 0.72 | |
| Victory Capital Management Inc | $76.98M | 0.28 | 687,931 | +14.97% | +$10.02M | 0.08 | |
| Standard Life | $75.55M | 0.28 | 675,159 | +537.4% | +$63.7M | 0.15 | |
| Barclays | $73.94M | 0.27 | 660,817 | -7.81% | -$6.26M | 0.03 | |
| Voya Investment Management | $73.97M | 0.27 | 661,064 | -43.04% | -$55.9M | 0.25 |